FDA “Critical Path” Will Emphasize Clinical Trial Simulation For Drugs
This article was originally published in The Pink Sheet Daily
Executive Summary
Computer modeling will play a crucial role in improving R&D innovation and efficiency, Woodcock says. The use of computer modeling will take encouragement from “up top” in industry as well as from FDA, an agency scientific advisor says.